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Abstract: Abdominal cancer is a widely prevalent group of tumours with a high level of mortality if
diagnosed at a late stage. Although the cancer death rates have in general declined over the past
few decades, the mortality from tumours in the hepatoduodenal area has significantly increased
in recent years. The broader use of minimal access surgery (MAS) for diagnostics and treatment
can significantly improve the survival rate and quality of life of patients after surgery. This work
aims to develop and characterise an appropriate technical implementation for tissue endogenous
fluorescence (TEF) and assess the efficiency of machine learning methods for the real-time diagnosis
of tumours in the hepatoduodenal area. In this paper, we present the results of the machine learning
approach applied to the optically guided MAS. We have elaborated tissue fluorescence approach
with a fibre-optic probe to record the TEF and blood perfusion parameters during MAS in patients
with cancers in the hepatoduodenal area. The measurements from the laser Doppler flowmetry
(LDF) channel were used as a sensor of the tissue vitality to reduce variability in TEF data. Also, we
evaluated how the blood perfusion oscillations are changed in the tumour tissue. The evaluated
amplitudes of the cardiac (0.6–1.6 Hz) and respiratory (0.2–0.6 Hz) oscillations was significantly
higher in intact tissues (p < 0.001) compared to the cancerous ones, while the myogenic (0.2–0.06 Hz)
oscillation did not demonstrate any statistically significant difference. Our results demonstrate that a
fibre-optic TEF probe accompanied with ML algorithms such as k-Nearest Neighbours or AdaBoost
is highly promising for the real-time in situ differentiation between cancerous and healthy tissues by
detecting the information about the tissue type that is encoded in the fluorescence spectrum. Also, we
show that the detection can be supplemented and enhanced by parallel collection and classification
of blood perfusion oscillations.
Keywords: liver cancer; endogenous fluorescence; laser Doppler flowmetry; blood perfusion;
minimally invasive interventions; machine learning
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1. Introduction
Abdominal cancer is a widely prevalent group of tumours with a high level of mortality if
diagnosed at a late stage. Although the cancer death rates have in general declined over the past
few decades, the mortality from tumours in the hepatoduodenal area specifically has increased in
recent years [1]. Moving towards the broader use of minimally invasive techniques for diagnosis
and treatment is promising to significantly improve the survival rate and quality of life of patients
after surgery. Minimally invasive techniques require the use of reliable tools for real-time feedback to
assist the surgeon. Usually, the manipulations in the operation field are conducted under ultrasound
or X-ray control and visualisation. While the methods can provide an exceptional accuracy of the
tool positioning, they hardly give sufficient information on the tissue type and, specifically, on the
tumour borders. Various approaches have been put forward to solve this issue. The optical methods
have been widely investigated in that respect and demonstrated high diagnostic potential in many
applications [2–5]. Despite the gradual transition from the in vivo single-point measurements towards
the in vivo imaging techniques, the use of fibre optical probes for the surgical guidance has great
potential to compete with the costly techniques and to significantly improve the outcome of the
routine procedures for cancer eradication. Most imaging approaches still need to address major issues
concerning the motion artefacts, real time imaging processing and the trade-off between the parameters
of resolution, frame rate and aperture diameter [6]. In particular, this set of limitations affects the
minimally invasive surgical interventions as one deals with the tools of low outer diameters being
applied in confined space of the abdominal cavity [7].
In recent years, there has been considerable interest in the measurements of the fluorescence
parameters to be applied for the diagnostics in minimally invasive surgery [8]. The methods are based
on the recording of the endogenous fluorescence. However, they often require the intravenous injection
of fluorescence dyes or molecular fluorescence probes specifically binding to tumour cells [9,10].
The association between TEF emission and changes in tissue metabolism as well as the blood circulation
and histological architecture offers a powerful diagnostic tool for direct monitoring of the malignancy
of studied biotissues. TEF, based on autofluorescence spectra registration, can provide comprehensive
information about the physiological or altered morphofunctional properties of cells and tissues,
including ones caused by oncology [11]. Due to high proliferation, tumour cells have increased
metabolic needs compared to normal ones [12], and tumour metabolism is associated with changes in
relative concentrations of NADH and FAD [13]. These endogenous fluorophores of cells and tissues
can serve as biomarkers for studying differences between tumour and non-tumour areas [14–18].
In the traditional approach, the TEF measurements were used to evaluate the changes in tissues
based on the comparison of the absolute values of the related emission parameters in tumour and
non-tumour areas. Nowadays, research tends to focus on machine learning (ML) approaches that
combine input feature sets in one or several diagnostic classifiers [19]. One promising application of
ML is MAS as the medical procedure commonly requires a high speed of the onsite decision making for
the surgeon. More recent evidence shows that the diagnostic techniques based on the measurements of
the intrinsic fluorescence aided with the machine learning algorithms can be used for distinguishing
malignant and benign colorectal tissue [20].
To the best of our knowledge, the applicability of ML in fluorescence liver cancer diagnostics has
not yet been studied thoroughly. The available published results in this research area either focus
on the MRI or CT studies [21], are limited using tumour-targeting fluorescent labels [22] or reported
results obtained ex vivo [23].
Recently, authors have published data on the evaluation of the liver tumours with the needle
optical probe combining TEF and diffuse reflectance measurements [24]. Except for that, despite high
interest and potential outcome, no one, to the best of our knowledge, has demonstrated results of the
ML application for cancer diagnosis that deploys data obtained by optical probe in vivo and in situ in
the hepatoduodenal area.
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In this work, we present results of the ML techniques to facilitate optically guided surgery on
tumours by the detection and classification of cancerous and healthy tissues. The data that we use in
our studies was obtained in vivo and in situ. In particular, we focus on cancers of the liver and bile duct
and collect and classify the data for TEF and blood perfusion. The focus on two types of data has the
following reason: it is known that in vivo recorded fluorescence spectra are influenced by many factors
such as the absorption by blood in the living tissue [25]. This blood-induced absorption attenuates and
changes the shape of the fluorescence signal [26]. To mitigate this problem, we additionally analyse the
parameters of the blood perfusion measured in living intact tissue (cf. [27]). For this, we deploy laser
Doppler flowmetry (LDF). LDF provides a powerful tool for the blood perfusion measurements and
analysis of rhythmic oscillations in the fine structure of microvascular blood flow. It was demonstrated
that LDF is a highly informative method across a range of medical conditions and general physiological
health monitoring applications. To record TEF and LDF blood perfusion parameters during MAS in
patients with cancers of liver and bile duct, we implemented a flexible optical fibre probe capable of
measurements in the hepatoduodenal area. We used ML techniques to detect the tumour borders
by classification of healthy and cancerous tissues using the TEF and LDF data. The general aim of
this work was to develop an appropriate technical implementation for TEF and LDF measurements
and to assess the efficiency of ML methods for real-time diagnosis of liver cancer and tumours in the
hepatoduodenal area.
2. Materials and Methods
2.1. Setup and In Situ Data Collection
The setup to collect data on TEF and LDF consists of a custom-built, flexible fibre-optical probe,
two LED sources for fluorescence excitation (at 365 nm and 450 nm), a set of fluorescent filters,
a CCD-based spectrometer and a laser Doppler flowmetry channel for blood perfusion measurements
that utilises a single-mode laser at 1064 nm. The prototype of the fibre-optical probe (Figure 1) has two
emitting fibres to excite TEF at wavelengths of 365 nm and 450 nm and a fibre to collect the fluorescence
emission (all fibres are of 400 µm in diameter). Moreover, the probe is equipped with one emitting
single-mode optical fibre and two multimode collecting fibres for the LDF channel. This configuration
enables to register the fluorescence of all major endogenous fluorophores in living tissue, as well as to
record the level of blood perfusion in the area of interest (Figure 2).
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The proposed setup was validated in the framework of limited tests in patients with obstructive
jaundice caused by liver cancer. The patient cohort comprised of 27 volunteers. The measurements
from the LDF channel were used as a sensor of the tissue vitality. The TEF spectra were recorded
primarily in the areas of interest demonstrated a stable level of blood perfusion of about 15 a.u. Figure 3
(top panel) shows the exemplary records of blood perfusion registered in the intact bile duct and
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in the cancer block. This procedure allowed us to avoid areas of necrosis and to decrease the TEF
data variation associated with the variable blood volume fraction in the tissue. The measurements
were performed during planned diagnostic and therapeutic interventions under ultrasound and X-ray
examination. For every patient, 8–10 spectra were taken at the excitation wavelength of 365 nm
and 450 nm. They were equally split between cancerous and intact tissues. In that way, 4–5 spectra
were measured for each class in a patient. The measurement points were evenly distributed over
the area of interest except for places with low blood perfusion prominent necrosis or covered with
blood. Also, two 1 min long LDF recordings were made for places with apparent tumour and normal
tissues respectively. The studies were conducted at the department of interventional radiology of
Orel Regional Clinical Hospital (Orel, Russia) and were approved by the local Committee for Human
Biomedical Research Ethics (record of the meeting No. 10 of 16.11.2017).
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the cancer cells can be absent on the surface of the cancerous tissues. This happens when the tumour
block compresses the healthy tissue where the probe is placed but does not permeate through the wall
of the organ. These aspects further contribute to the increase of the system’s LPE by leading to false
labelling of spectra used for the training and testing of ML models.Diagnostics 2020, 10, x FOR PEER REVIEW 5 of 11 
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and 816 nm s mpled with 2100 pixels. To build and determine s it ble machine learning models for
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In terms of data pre-processing, we first removed the data samples where the noise floor overlapped
with the actual fluorescence spectra. To further reduce the influence of noise, the remaining spectra
were smoothed using a FIR filter. In the next step, noisy, not informative sections at the beginning
(blue sides) of the spectra as well as at their (red) ends were cut off. This resulted in the reduced
dimensionality of each spectrum of (1, 1920) instead of the initial dimension of (1, 2100) that was
determined by the spectrometer pixel number.
The training and test sets were randomly split as follows: 199 samples for training and 40 samples
for testing in the case of the 356 nm channel and 120 samples for training and 40 samples for testing
in the case of the 450 nm channel. To increase the performance of our ML models, the data was
standardised by subtracting the data mean value and dividing the result by the standard deviation.
To further reduce the dimensionality of our training and test data, we applied the principal
component analysis (PCA) with 5 principal components. As Figure 5 shows, 5 principal components
retain more than 90% of the information stored in the spectra. The first two components having the
highest values carry the biggest part of this information. We interpret the first two components as
the indicators of the fluorescence peak intensity and its position in the spectrum. After the PCA is
performed, the dimension of each spectrum is only (1, 5). In our statistical experiments, we observe
a variation of the first two PCA components values by ±3% and much smaller variation in other
components. However, this variability does not prevent us from seeing a clear difference between the
first and the second component.
Five classification models and their performance in differentiating between the healthy and
cancerous tissues were considered for the TEF spectra of each channel as well as for the LDF blood
flow oscillations. Those are the k-Nearest-Neighbours (KNN) algorithm [28], a Decision Tree (DT) [29],
Support Vector Machines (SVM) [30] and such ensemble methods as the Random Forest (RF) [31] and
AdaBoost [32]. In the blood perfusion analysis, the logistic regression model was applied instead of
AdaBoost. A 10-fold validation was applied to evaluate the accuracy of each method. The accuracy
denotes the ratio between the rightly classified values, and all considered ones and measures how
close the predicted value of the class is to the true class label. Two further metrics that we used to
evaluate the classifiers’ performance are the sensitivity and the specificity. The sensitivity is the ratio
between the true positives and the sum of true positives and false negatives, i.e., the portion of actual
positives that are correctly predicted. The specificity measures the number of true negatives put into
relation to the sum of true negatives and false positives, it is the portion of actual negatives that are
correctly predicted [33]. The sensitivity is an important measure to accurately diagnose the cancerous
tissues, whereas the specificity determines how well the system detects healthy tissues. In an ideal
case, both sensitivity and specificity tend towards 100%. In the following, all three metrics (accuracy,
sensitivity and specificity) are evaluated as an average of 10 statistical experiments for which the data
was randomly shuffled each time.
When looking at Figure 3, we can assume that the information of the tissue type is encoded
in the frequency components of the blood perfusion time series. The oscillations in the cancerous
tissue are slower whereas the time series collected from healthy tissue exhibits more high-frequency
components. To validate the assumption and extract this information, we pre-process the LDF data by
means of the wavelet analysis with the Morlet wavelet taken as a mother function. We calculated the
integrated wavelet spectra (IWS) using the signal analysis technique in the frequency domain. Examples
of representative IWS for cancerous and normal tissues are presented in Figure 3 (bottom panel).
The length of the recordings allowed us to calculate 3 spectral ranges of the oscillations in the fine
structure of capillary blood flow corresponding to the cardiac (0.6–1.6 Hz), respiratory (0.2–0.6 Hz) and
myogenic activities (0.2–0.06 Hz) [34]. The maximal amplitude of the oscillations in every spectral
range was taken as a diagnostic parameter. One-Way ANOVA with Tukey’s post hoc test was used to
check the significance of the statistical variation between blood perfusion parameters measured in
the tumour and the intact tissue. Only demonstrated statistically significant difference parameters of
blood perfusion oscillations were used as the feature space for the ML methods.
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3. Results
As in the case with data pre-processing, the data evaluation for TEF was done using the Scikit-learn
library. The considered ML models underwent initial tuning in terms of the best prediction accuracy to
pick the best possible hyperparameters. The resulting KNN classifier had 4 neighbours with distance
weighting for both channels; also for both channels, the best maximum depth of the decision tree
turned out to be only 1; the SVM model had a regularisation parameter of Z = 0.1 and a linear kernel for
both 365 nm and 450 nm; the RF classifier for the 365 nm channel consisted of 5 estimators with a depth
of 3; whereas the RF model for the 450 nm channel had 7 estimators with a depth of 3; the AdaBoost
model consisted of 5 sub-estimators for each channel.
Tables 1 and 2 summarise the results for accuracy, sensitivity and specificity we achieved for
10 statistical experiments where the data used for training and testing was randomly shuffled each
time. The results are presented as a mean value ± standard deviation in percent.
As Table 1 shows, the results of the TEF classification exhibit higher values for the 450 nm channel
than for the 365 nm channel for all considered metrics. This suggests dropping the 365 nm channel in
future which might considerably simplify the setup. Additionally, the dropping of the 365 nm channel
would increase the in-field practicability of the suggested method. This is because the excitation
radiation of 365 nm lying within the UV spectrum induces higher phototoxicity for living tissues than
the light at 450 nm [35]. For TEF, the accuracy varies between 60% and 67% for the 365 nm channel and
between 62% and 72% for the 450 nm channel.
Table 1. Achieved results of Accuracy and Specificity in % for each classifier and each excitation
channel for TEF measurements.
Channel 365 nm 450 nm
Model Accuracy Sensitivity Specificity Accuracy Sensitivity Specificity
KNN 60 ± 8 41 ± 21 73 ± 12 62 ± 6 46 ± 21 78 ± 8
Decision Tree 67 ± 7 28 ± 25 89 ± 9 67 ± 8 27 ± 37 94 ± 13
SVM 67 ± 8 15 ± 28 96 ± 6 72 ± 6 28 ± 35 99 ± 2
Random Forest 65 ± 8 27 ± 27 86 ± 11 64 ± 7 28 ± 28 88 ± 8
AdaBoost 5 6 26 6 87 ± 7 64 ± 5 37 ± 37 86 ± 16
As discussed in Section 2.2, we assume a high LPE implicating that several spectra were falsely
labelled right at the beginning. We assume an LPE of around 15%. In this case, the accuracy is limited
by this value, meaning that even a perfect classifier would not be able to achieve better accuracy results
than around 85%. From this point of view, to achieve accuracy values up to 72% is highly promising.
In detail, from all considered values of accuracy, the SVM algorithm for the TEF data provides
the best performance. Moreover, in terms of specificity, SVM shows the best results, going to 96–99%
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well predicting the negative cases, i.e., the cases of healthy tissues. The second-best result is shown by
the DT model. However, if you consider the sensitivity values, both SVM and DT perform poorly on
the prediction of cancerous tissues, which is the most important aspect for in situ diagnosis. Taking
into account the value of sensitivity, the best performance is shown by KNN for both channels and
AdaBoost, specifically for the 450 nm channel. The considered Random Forest performs poorly in
terms of all three metrics.
In general, we observe a high variety in sensitivity values that manifests itself in high values of
standard deviation. This occurs due to the difficulties of the data collection described in Section 2.2
and poses the requirement to improve the data collection and labelling in further stages of the
approach development.
As for LDF, the evaluated amplitudes of the cardiac and respiratory oscillation were significantly
higher in intact tissues (p < 0.001) compared to the cancerous ones, while the myogenic oscillation
did not demonstrate any statistically significant difference. The results on the statistical analysis of
the differences in the oscillations in normal intact and cancerous tissues are presented in Figure 6.
The reason for the observed distinction of the amplitude values in the healthy and cancerous tissues
can lie in the mechanical properties of the tumour resulting in the dimming of the amplitude of the
pulse that propagates through the microvessels within the cancerous tissue.
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The results obtained by the ML models applied to the values of blood perfusion oscillations
obtained from wavelet transform (Table 2) suggest that the parameters especially of the cardiac
oscillations are of high a diagnostic value and can effectively supplement the TEF analysis and
classification. However, more clinical research and better feature extraction as well as the fine-tuning
of the ML models are needed to produce better prediction results and to correctly interpret them.
Table 2. Results of Accuracy and Specificity in % for each classifier for blood perfusion
rhythmic oscillations.
Channel Cardiac Oscilla ions Respiratory Oscillations
Model Accuracy Sensitivity Specificity Accur cy Sensitivity Specificity
KNN 58 ± 7 34 ± 26 82 ± 16 56 ± 10 35 ± 10 77 ± 18
Decision Tree 62 ± 7 61 ± 22 65 ± 24 55 ± 6 37 ± 20 72 ± 18
SVM 60 ± 9 26 ± 20 93 ± 8 59 ± 8 36 ± 19 81 ± 13
Random Forest 54 ± 15 57 ± 17 51 ± 30 58 ± 6 42 ± 14 73 ± 13
Logistic Regression 70 ± 7 52 ± 9 87 ± 9 64 ± 8 49 ± 11 79 ± 12
As Tabl 2 presents, the best results are achieved by logisti regression applied to classify he
cardiac oscillations. This suggests focussing only on the data obtained for cardiac oscillations and
to use log stic r gression to evaluate it in future. Further, reliable evaluation of the blood perfusion
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pulsations associated with the heart activity requires as much as twice shorter LDF recording duration
than the one required for the respiratory oscillations. As a result, the duration of the LDF recording
can be shortened.
4. Discussion
The challenge of more accurate data collection to significantly minimise the LPE still requires an
appropriate solution. Further development of the proposed multimodal approach by equipping it
with additional optical methods (e.g., diffuse reflectance spectroscopy or optical proximity sensor)
can be an option to improve the accuracy of the probe placement. An approach based on the diffuse
reflectance measurements might allow for a significant decrease in the influence of blood absorption
on the recorded TEF spectra.
A non-contact proximity sensor embedded in the probe combined with the subsequent automation
of the data collection at a fixed optimal distance might eliminate the negative effects of the sensor tip
pressure on the soft tissues under study. Moreover, the saline delivery subsystem for the pus, mucus
and blood removal from the tissue surface and optical probe cleaning during the procedure are also
considered to be promising for the improvement of the quality of the data collection.
Based on the achieved results, we believe that the use of the 365 nm channel can be dropped
in the further design development of the fibre-optic probe since it does not contribute to the overall
performance. We see that TEF analysis and classification can be assisted by the analysis of the LDF data
for cardiac oscillations. However, deeper-going studies with respect to the suitable feature extraction
and ML model hyper-parameters are needed to effectively supplement the TEF classification with LDF
classification. To improve the data quality and efficiency for the LDF analysis, the length of the blood
perfusion recordings can be shortened from 1 min to 30 s as it is enough for the suggested analysis of the
cardiac oscillations. As for the ML methods, AdaBoost and KNN models demonstrate the best results
in terms of accuracy, specificity, and sensitivity and should be considered for classifying cancerous and
noncancerous tissues in real-time in situ TEF diagnosis. The logistic regression is preferable for the
classification based on the blood perfusion oscillations data.
5. Conclusions
Our results clearly demonstrate that a fibre-optic TEF probe accompanied with ML algorithms such
as k-Nearest Neighbours or AdaBoost is highly promising for real-time in situ differentiation between
cancerous and healthy tissues by detection the information about the tissue type that is encoded in
the fluorescence spectrum. This detection can be supplemented and enhanced by parallel collection
and classification of blood perfusion rhythmic data, especially the one that denote cardiac oscillations.
Clearly, the data collection procedure as well as the design of the proposed fibre-optic probe have to be
improved. Once it is done, we are convinced that the proposed fibre probe together with the elaborated
ML techniques constitutes a highly promising device for a prompt and precise in situ decision-making
and would allow to choose the optimal surgical tactics during the tumour resection.
As a next step, we will elaborate a procedure for the collection of data with much higher quality
as well as improve the design of the fibre-optic probe by, for instance, dropping the 365 nm excitation
channel and introducing a non-contact proximity sensor.
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